P. Brent Ferrell - Concepedia

Author

P. Brent Ferrell

Vanderbilt University Medical Center ORCID

Also Known As

Evan J. Nguyen, McLeod, Howard L, P B Ferrell, P Brent Ferrell, P Ferrell, P. BRENT FERRELL, P. Brent Ferrell, P. Ferrell, P.B. Ferrell, Paul B. Ferrell

156

Publications

2.4K

Citations

H-Index

Concepts

All Affiliations

Vanderbilt University Medical Center Vanderbilt University University of California, Los Angeles The Barbara Ann Karmanos Cancer Institute University of Miami

About

P. Brent Ferrell is an author at Vanderbilt University Medical Center specializing in medicine, immunology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	13	1.1K
2	Health Sciences	4	4	276
3	Engineering	1	1	142
4	Natural Sciences	1	1	49
5	Biochemistry	1	1	49

P. Brent Ferrell

Publications

Citations

H-Index

Page 1

	Year	Citations
Carbamazepine, <i>HLA-B*1502</i> and Risk of Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: US FDA Recommendations P. Brent Ferrell, Howard L. McLeod Pharmacogenomics	2008	399
T cells specific for α-myosin drive immunotherapy-related myocarditis Margaret L. Axelrod, Wouter C. Meijers, Elles M. Screever, Nature Autoimmune DiseaseT CellsImmunodeficienciesImmunologyImmune Regulation	2022	281
Hematologic Complications of Immune Checkpoint Inhibitors Elizabeth J. Davis, Joe‐Elie Salem, Arissa Young, The Oncologist	2019	169
Tumor-specific MHC-II expression drives a unique pattern of resistance to immunotherapy via LAG-3/FCRL6 engagement Douglas B. Johnson, Mellissa J. Nixon, Yu Wang, JCI Insight ImmunologyImmunoeditingImmunologic MechanismAntigen ProcessingImmunotherapy	2018	155
Methods for discovery and characterization of cell subsets in high dimensional mass cytometry data Kirsten E. Diggins, P. Brent Ferrell, Jonathan M. Irish Methods EngineeringTumor HeterogeneityMedicineSpatial OmicsBioimage Analysis	2015	142
Olutasidenib alone or with azacitidine in IDH1-mutated acute myeloid leukaemia and myelodysplastic syndrome: phase 1 results of a phase 1/2 trial Justin M. Watts, Maria R. Baer, Jay Yang, The Lancet Haematology Phase 1/2Hematological MalignancyMyelodysplastic SyndromeMedicineMixed-phenotype Acute Leukemia	2022	111
Seroepidemiological study of relationships between Epstein-Barr virus and rheumatoid arthritis. P. Brent Ferrell, Carol T. Aitcheson, Gary R. Pearson, Journal of Clinical Investigation Rheumatoid DisorderRheumatologyGeometric Mean TiterAutoimmune DiseaseEpstein-barr Virus	1981	108
Mass cytometry deep phenotyping of human mononuclear phagocytes and myeloid-derived suppressor cells from human blood and bone marrow Mikaël Roussel, P. Brent Ferrell, Allison R. Greenplate, Journal of Leukocyte Biology	2017	87
The use of venetoclax‐based salvage therapy for post‐hematopoietic cell transplantation relapse of acute myeloid leukemia Michael Byrne, Nathalie Danielson, Salyka Sengsayadeth, American Journal of Hematology Cell TherapyMixed-phenotype Acute LeukemiaImmunologyAllogeneic HctMyeloid Neoplasia	2020	78
Metabolic alterations mediated by STAT3 promotes drug persistence in CML Sweta B. Patel, Travis Nemkov, Davide Stefanoni, Leukemia	2021	51

Page 1